Arimoclomol in Sporadic Inclusion Body Myositis

计划入组 24 人 · 首次发布于 2008 年 10 月 9 日

Sporadic Inclusion Body Myositis Natural History Study

计划入组 150 人 · 首次发布于 2021 年 9 月 16 日

Immune Abnormalities in Sporadic Inclusion Body Myositis

计划入组 80 人 · 首次发布于 2002 年 2 月 8 日

Hereditary inclusion body myopathy gene therapy(Gradalis, Inc.)

Inonotus obliquus fruiting body

Trametes versicolor fruiting body

Bath & Body Works

United States

BALI BODY PTY LTD

Australia

BODY ARMOUR PTY LTD

Australia

Novel Gene Therapy AVGN7.2 Shows Promising Safety Profile in Preclinical Study for Inclusion Body Myositis

Abcuro's Ulviprubart Misses Primary Endpoints in Inclusion Body Myositis Trial, Shows Promise in Mild-to-Moderate Patients

Abcuro Secures $200M Series C to Advance Phase II/III Trial for Rare Muscle Disease Treatment